Cellceutix Comments on New York Times Article Heralding P53 Drugs as the …

Published December 24, 2012

Cellceutix Comments on New York Times Article Heralding p53 Drugs as the …

Filed under: residential drug treatment programs

BEVERLY, MA–(Marketwire – Dec 24, 2012) – Cellceutix Corporation ( OTCBB : CTIX) (the "Company"), a clinical stage biopharmaceutical company focused on discovering small molecule drugs to treat unmet medical conditions, including drug-resistant …
Read more on Marketwire (press release)

Glenmark inks drug development pact with Forest Laboratories

Filed under: residential drug treatment programs

The company's unit, Glenmark Pharmaceuticals SA (GPSA), has entered into an agreement with Forest Laboratories on a collaboration for the development of novel mPGES-1 inhibitors to treat chronic inflammatory conditions, including pain, Glenmark …
Read more on Economic Times

'Newfound strength'

Filed under: residential drug treatment programs

Additionally, Prodigals Community is only available to those who have a history of chronic substance-abuse relapse. To be eligible for admission, the person must have been in at least one treatment program prior to the application. Prodigals Community …
Read more on Winston-Salem Journal